Cited 0 times in 
Cited 1821 times in 
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Omata, Masao | - |
| dc.contributor.author | Cheng, Ann-Lii | - |
| dc.contributor.author | Kokudo, Norihiro | - |
| dc.contributor.author | Kudo, Masatoshi | - |
| dc.contributor.author | Lee, Jeong Min | - |
| dc.contributor.author | Jia, Jidong | - |
| dc.contributor.author | Tateishi, Ryosuke | - |
| dc.contributor.author | Han, Kwang Hyup | - |
| dc.contributor.author | Chawla, Yoghesh K. | - |
| dc.contributor.author | Shiina, Shuichiro | - |
| dc.contributor.author | Jafri, Wasim | - |
| dc.contributor.author | Alcantara Payawal, Diana | - |
| dc.contributor.author | Ohki, Takamasa | - |
| dc.contributor.author | Ogasawara, Sadahisa | - |
| dc.contributor.author | Chen, Pei-Jer | - |
| dc.contributor.author | Lesmana, Cosmas Rinaldi A. | - |
| dc.contributor.author | Lesmana, Laurentius A. | - |
| dc.contributor.author | Gani, Rino A. | - |
| dc.contributor.author | Obi, Shuntaro | - |
| dc.contributor.author | Dokmeci, A. Kadir | - |
| dc.contributor.author | Sarin, Shiv Kumar | - |
| dc.date.accessioned | 2023-08-09T02:38:56Z | - |
| dc.date.available | 2023-08-09T02:38:56Z | - |
| dc.date.created | 2023-08-11 | - |
| dc.date.issued | 2017-07 | - |
| dc.identifier.issn | 1936-0533 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/195711 | - |
| dc.description.abstract | There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia-Pacific region, where HCC is one of the leading public health problems. Since the "Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines" meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia-Pacific region, which has a diversity of medical environments. | - |
| dc.description.statementOfResponsibility | open | - |
| dc.format | application/pdf | - |
| dc.language | English | - |
| dc.publisher | Springer | - |
| dc.relation.isPartOf | Hepatology International | - |
| dc.relation.isPartOf | HEPATOLOGY INTERNATIONAL | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Omata, Masao | - |
| dc.contributor.googleauthor | Cheng, Ann-Lii | - |
| dc.contributor.googleauthor | Kokudo, Norihiro | - |
| dc.contributor.googleauthor | Kudo, Masatoshi | - |
| dc.contributor.googleauthor | Lee, Jeong Min | - |
| dc.contributor.googleauthor | Jia, Jidong | - |
| dc.contributor.googleauthor | Tateishi, Ryosuke | - |
| dc.contributor.googleauthor | Han, Kwang Hyup | - |
| dc.contributor.googleauthor | Chawla, Yoghesh K. | - |
| dc.contributor.googleauthor | Shiina, Shuichiro | - |
| dc.contributor.googleauthor | Jafri, Wasim | - |
| dc.contributor.googleauthor | Alcantara Payawal, Diana | - |
| dc.contributor.googleauthor | Ohki, Takamasa | - |
| dc.contributor.googleauthor | Ogasawara, Sadahisa | - |
| dc.contributor.googleauthor | Chen, Pei-Jer | - |
| dc.contributor.googleauthor | Lesmana, Cosmas Rinaldi A. | - |
| dc.contributor.googleauthor | Lesmana, Laurentius A. | - |
| dc.contributor.googleauthor | Gani, Rino A. | - |
| dc.contributor.googleauthor | Obi, Shuntaro | - |
| dc.contributor.googleauthor | Dokmeci, A. Kadir | - |
| dc.contributor.googleauthor | Sarin, Shiv Kumar | - |
| dc.identifier.doi | 10.1007/s12072-017-9799-9 | - |
| dc.relation.journalcode | J00986 | - |
| dc.identifier.eissn | 1936-0541 | - |
| dc.identifier.pmid | 28620797 | - |
| dc.subject.keyword | Hepatocellular carcinoma | - |
| dc.subject.keyword | Asia-Pacific | - |
| dc.subject.keyword | APASL | - |
| dc.subject.keyword | Treatment algorithm | - |
| dc.contributor.alternativeName | Han, Kwang Hyub | - |
| dc.contributor.affiliatedAuthor | Han, Kwang Hyup | - |
| dc.identifier.scopusid | 2-s2.0-85020518973 | - |
| dc.identifier.wosid | 000404684600001 | - |
| dc.citation.volume | 11 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 317 | - |
| dc.citation.endPage | 370 | - |
| dc.identifier.bibliographicCitation | Hepatology International, Vol.11(4) : 317-370, 2017-07 | - |
| dc.identifier.rimsid | 80560 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
| dc.subject.keywordAuthor | Asia-Pacific | - |
| dc.subject.keywordAuthor | APASL | - |
| dc.subject.keywordAuthor | Treatment algorithm | - |
| dc.subject.keywordPlus | HEPATITIS-B-VIRUS | - |
| dc.subject.keywordPlus | ACID-ENHANCED MRI | - |
| dc.subject.keywordPlus | PERCUTANEOUS ETHANOL INJECTION | - |
| dc.subject.keywordPlus | GD-EOB-DTPA | - |
| dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
| dc.subject.keywordPlus | GAMMA-CARBOXY PROTHROMBIN | - |
| dc.subject.keywordPlus | FATTY LIVER-DISEASE | - |
| dc.subject.keywordPlus | SUSTAINED VIROLOGICAL RESPONSE | - |
| dc.subject.keywordPlus | STEREOTACTIC BODY RADIOTHERAPY | - |
| dc.subject.keywordPlus | SERUM ALPHA-FETOPROTEIN | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
| dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.